- Advertisement -
- Advertisement -

Related

Rhenmans segertåg fortsätter

Latest Report

- Advertisement -

Stockholm (HedgeNordic.com) – Rhenman & Partners hedgefond, Rhenman Healthcare Equity L/S, har återigen visat framfötterna. Efter ett osedvanligt starkt fjolår där fonden steg med dryga 55%, har 2014 visat på fortsatta framgångar. Under augusti månad steg fonden 7,45% vilket tar avkastningen för helåret till 20,27%. Fonden har två år i rad utnämnts till bästa aktiehedgefond vid Nordic Hedge Awards.

I sitt månadsbrev skriver förvaltaren att klimatet inom biotech-sektorn gynnades kraftigt av att läkemedelbolaget Roche lade ett bud på Intermune under månaden. Fondens innehav i Intermune var dock försumbart och istället gynnades fondens utveckling av innehav i Salix (uppköpssekulationer samt förhoppningar utökade godkännanden för läkemedlen Xifaxan och Relistor), Gilead (fortsatt extremt starka försäljningssiffror för hepatit C läkemedlet Sovaldi och förhoppningar om ökad acceptans för preparatet utanför USA) samt Biomarin (som anses vara en uppköpskandidat som inte hängt med utvecklingen för biotech bolag). Bland negativa resultatbidrag märktes innehav som Meda (svaga resultat), Thoratec (svaga resultat) samt Revance (oro för krav på ökad dokumentation vad avser deras botox liknande produkter).

Förvaltaren har en fortsatt positiv syn på fonden för helåret trots fortsatt geopolitisk oro.

Bild: (c) ollyy—shutterstock.com 

 

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Kamran Ghalitschi
Kamran Ghalitschi
Kamran has been working in the financial industry since 1994 and has specialized on client relations and marketing. Having worked with retail clients in asset management and brokerage the first ten years of his career for major European banks, he joined a CTA / Managed Futures fund with 1,5 Billion USD under management where he was responsible for sales, client relations and operations in the BeNeLux and Nordic countries. Kamran joined a multi-family office managing their own fund of hedgefunds with 400 million USD AuM in 2009. Kamran has worked and lived in Vienna, Frankfurt, Amsterdam and Stockholm. Born in 1974, Kamran today again lives in Vienna, Austria.

Latest Articles

Playing ‘Moneyball’ for Investors

Having managed the opportunistic hedge fund Pensum Global Opportunities under the Pensum Asset Management umbrella since 2022, Sector co-founder Peter Andersland has now established...

One Big Winner Lifts Accendo Into the Top Ten

When your portfolio holds six names, one big winner can move the needle in a major way. For Accendo Capital, September proved just that....

Slim Nordic Line-Up at HFM Awards

With Intelligence has revealed the shortlist for the HFM European Performance Awards 2025, featuring an unusually small number of Nordic hedge funds among this...

Record Gold, Rising Momentum

The NHX CTA Index gained in September 2025, supported by a broad-based trend environment. Most of the profits came from precious metals, as gold...

From Rocky Starts to Solid Returns and Milestones

Lynx Asset Management, best known for its flagship trend-following program Lynx, has in recent years expanded its product offering with the launch of Lynx...

Europe’s Infrastructure Transformation: Where the Smart Money is Going

Infrastructure is at the heart of Europe’s economic transformation. Richard Marshall, Head of Infrastructure Research at DWS, explores how subsectors like data centres, renewable...

Allocator Interviews

In-Depth: High Yield

Voices

Request for Proposal

- Advertisement -
HedgeNordic
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.